Search results
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 1 hour agoModerna stock broke out for the first time in a year on Thursday after beating Wall Street's...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 2 hours agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 hours agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 11 hours agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 7 hours agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 10 hours agoModerna stock soared on Wednesday after its first-quarter earnings report sailed past Wall Street’s...
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 10 hours agoModerna (MRNA) delivered earnings and revenue surprises of 14.48% and 33.88%, respectively, for the...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo News· 11 hours ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 5 hours agoImage source: The Motley Fool. Moderna (NASDAQ: MRNA) Q1 2024 Earnings Call May 02, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Moderna ends gene editing alliance with Metagenomi
BioPharma Dive via Yahoo Finance· 10 hours agoMetagenomi said the companies’ decision to part ways followed a “strategic prioritization” undertaken by Moderna, which has made several investments in...
